3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
21
Rectal Neoplasms
10
Colonic Neoplasms
6
Pancreatic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Adenocarcinoma Of Esophagus
3
Peritoneal Neoplasms
2
Neoplasms
2
Liver Neoplasms
2
Esophageal Neoplasms
2
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Neuropathy, Painful
1
Neuralgia
1
Neoplasm Recurrence, Local
1
Malignant Solid Tumour
1
Locally Advanced Pancreatic Carcinoma(LAPC)
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Disease Progression
1
Cold Hypersensitivity
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Advanced Rectal Cancer
1
Advanced Primary Liver Cancer
1
Adenocarcinoma of the Lower Rectum
1
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
Folfox protocol
×
Clear all
No trials found.